Janine Papon

123 I- N -(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging

Nicole Moins, M. D’Incan, J. Bonafous et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 72 citations

Medicine, Oncology, Radiology +16

Evaluation of Radiolabeled (Hetero)Aromatic Analogues of <i>N</i>-(2-diethylaminoethyl)-4-iodobenzamide for Imaging and Targeted Radionuclide Therapy of Melanoma

Jean‐Michel Chezal, Janine Papon, P. Labarre et al. · Journal of Medicinal Chemistry · 2008 · 71 citations

Medicine, Nuclear Medicine, Oncology +17

Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples.

Daniel Morvan, Aïcha Demidem, Janine Papon et al. · PubMed · 2002 · 65 citations

Life Sciences, Oncology, Pharmacology +17

Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciences

Jean‐Luc Guerquin‐Kern, F. Hillion, Jean‐Claude Madelmont et al. · BioMedical Engineering OnLine · 2004 · 59 citations · Full text

Medicine, Cell Biology, Oncology +17

Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: Demonstration of phospholipid metabolism alterations

Daniel Morvan, Aïcha Demidem, Janine Papon et al. · Magnetic Resonance in Medicine · 2003 · 57 citations · Full text

Life Sciences, Biochemistry, Cancer Biology +17